Pharmaceuticals output up 21%

Biomedical manufacturing output expanded 19.5% in December.

The Singapore Economic Development Board reported:

Output of the biomedical manufacturing cluster expanded 19.5% in December 2012 compared to the same period a year ago.

The pharmaceuticals segment climbed 21.0%, mainly due to a different mix of active pharmaceutical ingredients being produced.

Robust export demand for medical devices drove the medical technology segment to record a gain of 11.8%.

On a year-to-date basis, output of the biomedical manufacturing cluster increased 9.9%, compared to the same period a year ago.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia